Key stats
About Xtrackers II Rolling Target Maturity Sept 2027 EUR High Yield UCITS ETF
Home page
Inception date
Aug 20, 2025
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
DWS Investment SA
ISIN
LU1109941689
The aim is for your investment to reflect the performance of the iBoxx EUR Liquid High Yield 2027 3-Year Rolling Index (the Reference Index). The Reference Index aims to reflect the market value weighted performance of liquid
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Corporate
Bonds, Cash & Other100.00%
Corporate97.01%
Cash2.78%
Mutual fund0.21%
Stock breakdown by region
Europe87.36%
North America9.26%
Asia3.38%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
XRTM top holdings are Teva Pharmaceutical Finance Netherlands II BV 3.75% 09-MAY-2027 and TK Elevator Midco GmbH 4.375% 15-JUL-2027, occupying 3.09% and 3.00% of the portfolio correspondingly.
No, XRTM doesn't pay dividends to its holders.
XRTM shares are issued by Deutsche Bank AG under the brand Xtrackers. The ETF was launched on Aug 20, 2025, and its management style is Passive.
XRTM expense ratio is 0.30% meaning you'd have to pay 0.30% of your investment to help manage the fund.
XRTM invests in bonds.